alitretinoin
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hand Dermatoses
Conditions
Hand Dermatoses
Trial Timeline
Apr 1, 2006 → May 1, 2007
NCT ID
NCT00309621About alitretinoin
alitretinoin is a phase 3 stage product being developed by Basilea Pharmaceutica for Hand Dermatoses. The current trial status is completed. This product is registered under clinical trial identifier NCT00309621. Target conditions include Hand Dermatoses.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01407679 | Phase 2 | Terminated |
| NCT00519675 | Phase 3 | Completed |
| NCT00309621 | Phase 3 | Completed |
| NCT00124436 | Phase 3 | Completed |
| NCT00124475 | Phase 3 | Completed |
Competing Products
17 competing products in Hand Dermatoses
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Lebrikizumab + Placebo | Eli Lilly | Phase 3 | 77 |
| Methylprednisolone Tablet | Johnson & Johnson | Phase 2/3 | 65 |
| ABT-981 + Placebo for ABT-981 | AbbVie | Phase 2 | 52 |
| Pimecrolimus Cream 1% | Novartis | Phase 3 | 77 |
| tocilizumab + saline solution | Roche | Phase 3 | 77 |
| denosumab + Placebo | Amgen | Phase 2 | 51 |
| Dupilumab + Placebo | Sanofi | Phase 2 | 51 |
| dupilumab + Placebo | Sanofi | Phase 3 | 76 |
| clobetasol propionate | GSK plc | Approved | 84 |
| urea 40% cream + fluocinonide 0.05% cream + tazarotene 0.1% cream + bland emollient cream (Udderly smooth® Udder Cream) | Bayer | Phase 2 | 49 |
| Ruxolitinib cream + Vehicle | Incyte | Phase 3 | 74 |
| Ruxolitinib cream + Vehicle | Incyte | Phase 2 | 49 |
| Ruxolitinib | Incyte | Phase 1/2 | 38 |
| Ruxolitinib cream + Vehicle | Incyte | Phase 3 | 74 |
| ARQ-252 cream 0.3% + ARQ-252 cream 0.1% + ARQ-252 Vehicle Cream | Arcutis Biotherapeutics | Phase 1/2 | 36 |
| alitretinoin | Basilea Pharmaceutica | Phase 3 | 72 |
| alitretinoin | Basilea Pharmaceutica | Phase 3 | 72 |
Other Products from Basilea Pharmaceutica
ceftobiprole medocaril + vancomycin+aztreonamPhase 3
72
alitretinoinPhase 3
72
Fosmanogepix + Fosmanogepix + Caspofungin + Fluconazole + Placebo + Placebo + Placebo + PlaceboPhase 3
72
ceftobiprole medocaril + Vancomycin plus CeftazidimePhase 3
72
ceftobiprole plus placebo + linezolid plus ceftazidimePhase 3
72